Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dynamic Contrast Enhanced MRI (DCE-MRI) Assessment of the Vascular Changes Induced With Bevacizumab Alone and in Combination With Interferon-α in Patients With Advanced Renal Cell Carcinoma

NCT00873236 is registered in ClinicalTrials.gov with Mount Vernon Cancer Centre at Mount Vernon Hospital as lead sponsor.

NCT NCT00873236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00873236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dynamic Contrast Enhanced MRI (DCE-MRI) Assessment of the Vascular Changes Induced With Bevacizumab Alone and in Combination With Interferon-α in Patients With Advanced Renal Cell Carcinoma
Lead sponsor
Mount Vernon Cancer Centre at Mount Vernon Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2008
Completion date
Not reported
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer